KNOZ, Martin, Jakub HOLOUBEK, Břetislav LIPOVÝ, Martin FALDYNA, Radka CHALOUPKOVÁ, Veronika PAVLINAKOVA, Johana MUCHOVA, Jana BRTNIKOVA, Jiří JARKOVSKÝ and Lucy VOJTOVA. Evaluation of viscoelastic parameters and photo-based assessment of newly developed dermal substitutes modified with thermostabilized fibroblast growth factor 2. Burns. London: ELSEVIER SCI LTD, 2024, vol. 50, No 6, p. 1586-1596. ISSN 0305-4179. Available from: https://dx.doi.org/10.1016/j.burns.2024.03.020.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Evaluation of viscoelastic parameters and photo-based assessment of newly developed dermal substitutes modified with thermostabilized fibroblast growth factor 2
Authors KNOZ, Martin (203 Czech Republic, belonging to the institution), Jakub HOLOUBEK (203 Czech Republic, belonging to the institution), Břetislav LIPOVÝ (203 Czech Republic, belonging to the institution), Martin FALDYNA (203 Czech Republic), Radka CHALOUPKOVÁ (203 Czech Republic), Veronika PAVLINAKOVA (203 Czech Republic), Johana MUCHOVA (203 Czech Republic), Jana BRTNIKOVA (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Lucy VOJTOVA (203 Czech Republic).
Edition Burns, London, ELSEVIER SCI LTD, 2024, 0305-4179.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30212 Surgery
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.700 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.burns.2024.03.020
UT WoS 001252447100001
Keywords in English Dermal substitute; Cutometry; Fibroblast grow factor 2; Scar; Visual assessment; Animal experiment
Tags 14110229, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 9/7/2024 12:12.
Abstract
Background: The purpose of dermal substitutes is to mimic the basic properties of the extracellular matrix of human skin. The application of dermal substitutes to the defect reduces the formation of hypertrophic scars and improves the scar quality. This study aims to develop an original dermal substitute enriched with stable fibroblast growth factor 2 (FGF2-STAB (R)) and test it in an animal model. Methods: Dermal substitutes based on collagen/chitosan scaffolds or collagen/chitosan scaffolds with nanofibrous layer were prepared and enriched with FGF2-STAB (R) at concentrations of 0, 0.1, 1.0, and 10.0 mu g.cm(-2). The performance of these dermal substitutes was tested in vivo on artificially formed skin defects in female swine. The outcomes were evaluated using cutometry at 3 and 6 months. In addition, visual appearance was assessed based on photos of the scars at 1-month, 3-month and 6-month follow-ups using Yeong scale and Visual Analog Scale. Results: The dermal substitute was fully integrated into all defects and all wounds healed successfully. FGF2-STAB (R)-enriched matrices yielded better results in cutometry compared to scaffolds without FGF2. Visual evaluation at 1, 3, and 6 months follow-ups detected no significant differences among groups. The FGF2-STAB (R) effectiveness in improving the elasticity of scar tissues was confirmed in the swine model. This effect was independently observed in the scaffolds with nanofibres as well as in the scaffolds without nanofibres. Conclusion: The formation of scars with the best elasticity was exhibited by addition 1.0 mu g.cm(-2) of FGF2-STAB (R) into the scaffolds, although it had no significant effect on visual appearance at longer follow-ups. This study creates the basis for further translational studies of the developed product and its progression into the clinical phase of the research.
Links
NU22-08-00454, research and development projectName: Biomimetický vícevrstevný buněčný nosič čtvrté generace pro jednokrokovou úplnou náhradu kůže: z laboratoře do klinické aplikace
Investor: Ministry of Health of the CR, Subprogram 1 - standard
90251, large research infrastructuresName: CzechNanoLab II
PrintDisplayed: 19/7/2024 15:20